U.S. drugmaker Pfizer pauses new studies due to coronavirus pandemic - (Yahoo!News via NewsPoints Desk)

  • Pfizer stated Wednesday that it would be postponing patient recruitment in new and ongoing global trials for three weeks due to the COVID-19 pandemic, as reported in Yahoo!News.

  • According to the company, the decision excludes certain studies that are recruiting patients with life-threatening conditions who have few or no other therapeutic options.

  • The move follows similar actions by other drugmakers, including Eli Lilly and Bristol Myers Squibb.

To read more NewsPoints articles, click here.